Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
非人灵长类结核杆菌生存的遗传要求
基本信息
- 批准号:8074923
- 负责人:
- 金额:$ 56.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAerosolsAgeAlveolarAnabolismAnimalsAntitubercular AgentsAttenuatedAutopsyBacillus (bacterium)BeliefBiological AssayBody TemperatureC-reactive proteinCCL19 geneCCL2 geneCCL7 geneCD4 Positive T LymphocytesCatabolismCaviaCell WallCellsCessation of lifeCharacteristicsCholesterolChromosomesChronicClinicalCommunicable DiseasesConfocal MicroscopyDNA RepairDefectDevelopmentDiseaseDoseDrug resistanceEmergency SituationEnvironmentEnzyme-Linked Immunosorbent AssayExhibitsFailureFamilyFatty AcidsGenesGeneticGenomeGranulomaGranulomatousGrowthHistopathologyHumanHypersensitivity skin testingHypoxiaImmune systemIn Situ HybridizationIndividualInfectionInflammatoryInterleukin-12IrrigationLesionLibrariesLiverLungLung Lavage FluidMacaca mulattaMammalian CellMeasurementMeasuresMetabolismMinorityModelingMonkeysMusMycobacterium tuberculosisNitrate ReductasesNutrientOperonOutputPathogenesisPathologyPathway interactionsPeptidoglycanPharmaceutical PreparationsPhasePhenotypePhosphotransferasesPhysiologicalPlayPrimatesProcessProductionPulmonary TuberculosisRegulonRelative (related person)ReportingResistanceRestReverse Transcriptase Polymerase Chain ReactionRoleSamplingSerumSimian Acquired Immunodeficiency SyndromeSouthern BlottingSpleenStagingSterolsStressSystemTestingTimeTuberculosisTuberculosis VaccinesVaccinesValidationVirulenceVirulence FactorsVirulentWeightarabanattenuationbasehygromycin Aimmune activationimmunopathologyin vivolipid transportlymph nodesmacrophagemalemembermortalitymouse modelmutantnitrate reductasenonhuman primateperipheral bloodpublic health relevanceresearch studyresponsesensortransposon site hybridizationtuberculosis drugsvector
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global infectious disease emergency. Each year an estimated 8 million people develop, and about two million people die of TB. Synergy with AIDS, the emergence of drug-resistance and the lack of effective anti-TB drugs and vaccines has worsened this situation. New drugs and vaccines are urgently needed to effectively control TB. This requires a better understanding of how Mtb adapts to a wide-variety of environmental conditions, inevitably faced by it during the various stages of infection. Nonhuman Primates (NHPs), arguably, best model critical aspects of TB. Analysis of the mechanisms employed by Mtb to successfully infect and persist in NHP lungs would therefore be very useful. We studied genes essential for growth/survival of Mtb in the NHP lungs experimentally exposed to high doses of aerosols of an Mtb transposon mutant library. In this acute model of TB, 33.13% of all tested mutants were attenuated for in-vivo growth compared to the mouse model where only ~6% of all mutants are attenuated. The Mtb mutants attenuated for in-vivo survival in primates were involved in the transport of lipid virulence factors; biosynthesis of cell-wall arabinan and peptidoglycan, fatty-acids and polyketides; DNA repair; sterol metabolism and mammalian cell-entry (mce). Our study highlights the various virulence-mechanisms employed by Mtb for infection and to overcome the hostile environment encountered during infection of NHP lungs. We would like to leverage our ability to model the various clinical phases of human TB - acute, pulmonary TB, chronic-progressive TB and latent, asymptomatic TB in NHPs - to study the growth/survival phenotype profiles of Mtb mutants. Further, we would like to better understand the role of two Mtb pathways crucial for virulence and pathogenesis, using the NHP model. These include the mce1/mce4 operons, whose members were among mutants that were attenuated for growth in NHP lungs; and members of the dos regulon, which were surprisingly not attenuated in NHP lungs, in-spite of their well-defined roles in latency, persistence and defense against hypoxia.
PUBLIC HEALTH RELEVANCE: Tuberculosis (TB) is a global emergency, responsible for the death of an estimated 2 million people annually. Monkeys, due to their genetic and physiological similarities to humans, are a very good animal system to model TB. Out of the several hundreds of genes present in the chromosome of the tubercle bacillus, we have determined which ones are needed to establish a successful infection in the lungs of monkeys. These results will be compared to those obtained from animals with TB/AIDS co-infection. Genes from the mce (mammalian cell entry) family were among those which were attenuated in the NHP lungs. We will perform functional studies using Mycobacterium tuberculosis (Mtb) and defined mutants in mce genes, using our monkey model, to better understand their role in disease process.
描述(由申请人提供):结核病(TB)由结核分枝杆菌(Mtb)引起,是一种全球性传染病紧急情况。每年估计有800万人患上结核病,约200万人死于结核病。与艾滋病的协同作用、抗药性的出现以及缺乏有效的抗结核药物和疫苗使这一局势恶化。迫切需要新的药物和疫苗来有效控制结核病。这需要更好地了解结核分枝杆菌如何适应各种各样的环境条件,这些条件是结核分枝杆菌在感染的各个阶段不可避免地面临的。 非人灵长类动物(NHP)可以说是结核病关键方面的最佳模型。因此,分析结核分枝杆菌成功感染NHP肺并在NHP肺中持续存在的机制将非常有用。我们研究了NHP肺中结核分枝杆菌生长/存活所必需的基因,实验暴露于高剂量的结核分枝杆菌转座子突变库的气溶胶。在该急性TB模型中,所有测试突变体中的33.13%针对体内生长被减毒,而小鼠模型中所有突变体中仅约6%被减毒。在灵长类动物体内存活的减毒Mtb突变体参与脂质毒力因子的运输;细胞壁阿拉伯聚糖和肽聚糖、脂肪酸和聚酮的生物合成; DNA修复;固醇代谢和哺乳动物细胞进入(mce)。我们的研究强调了结核分枝杆菌感染所采用的各种毒力机制,并克服了NHP肺部感染期间遇到的恶劣环境。 我们希望利用我们的能力来模拟人类结核病的各种临床阶段-急性肺结核、慢性进展性结核和NHP中的潜伏性无症状结核-以研究Mtb突变体的生长/存活表型谱。此外,我们想更好地了解两个结核分枝杆菌途径的毒力和发病机制至关重要的作用,使用NHP模型。其中包括mce 1/mce 4操纵子,其成员属于在NHP肺中生长减弱的突变体;和dos调节子的成员,令人惊讶的是,它们在NHP肺中没有减弱,尽管它们在潜伏期、持续性和缺氧防御中具有明确的作用。
公共卫生相关性:结核病(TB)是一种全球性紧急情况,每年造成约200万人死亡。 由于猴子与人类的遗传和生理相似性,它们是一种非常好的结核病模型动物系统。 在结核杆菌染色体中存在的数百个基因中,我们已经确定了在猴子的肺部建立成功感染所需的基因。这些结果将与从结核病/艾滋病合并感染的动物中获得的结果进行比较。来自mce(哺乳动物细胞进入)家族的基因是在NHP肺中减毒的基因之一。我们将使用结核分枝杆菌(Mtb)和mce基因中定义的突变体进行功能研究,使用我们的猴模型,以更好地了解它们在疾病过程中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deepak Kaushal其他文献
Deepak Kaushal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deepak Kaushal', 18)}}的其他基金
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
诱导支气管相关淋巴组织在潜伏性结核病中的作用
- 批准号:
10764569 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Baboon model of long term effects of SARS-CoV-2 infection
SARS-CoV-2 感染长期影响的狒狒模型
- 批准号:
10413419 - 财政年份:2021
- 资助金额:
$ 56.79万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
10444441 - 财政年份:2021
- 资助金额:
$ 56.79万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10757101 - 财政年份:2020
- 资助金额:
$ 56.79万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10440359 - 财政年份:2020
- 资助金额:
$ 56.79万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10211126 - 财政年份:2020
- 资助金额:
$ 56.79万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10083390 - 财政年份:2020
- 资助金额:
$ 56.79万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 56.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 56.79万 - 项目类别:
Standard Grant














{{item.name}}会员




